Berry Genomics Co.,Ltd. Posted 17.1 Million Yuan Net Loss in First Half of 2022

Berry Genomics Co.,Ltd. (成都市贝瑞和康基因技术股份有限公司) (000710.SZ) reported a net loss of 17.1 million yuan in the first half of 2022, reversing a net profit of 31.5 million yuan for the same period in the previous year.

Meanwhile, the company posted 680.3 million yuan in revenue, down 7.3% year-on-year.

At the end of the reporting period, it had 3.4 billion yuan in total assets and 833.4 million yuan in total liabilities, with a liability-to-asset ratio of 24.8%.